UBS Group
ACTU

UBS Group’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

UBS Group’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$14.3K Buy
2,347
+368
+19% +$2.25K ﹤0.01% 7342
2025
Q1 		$13.4K Buy
1,979
+45
+2% +$305 ﹤0.01% 7154
2024
Q4 		$15.4K Buy
+1,934
New +$15.4K ﹤0.01% 6815